ML22124A148

From kanterella
Jump to navigation Jump to search
(Ccnpp) Control Element Assembly (CEA) Recovery Time Improvement Project LAR Pre-Submittal Redacted (Public)
ML22124A148
Person / Time
Site: Calvert Cliffs  Constellation icon.png
Issue date: 05/10/2022
From:
Constellation Energy Nuclear Group
To: Jason Paige
NRC/NRR/DORL/LPL1
Marshall M, NRR/DORL/LPL1, 415-2781
Shared Package
ML22124A157 List:
References
Download: ML22124A148 (4)


Text

Calvert Cliffs Nuclear Power Plant Control Element Assembly Recovery Time Improvement Project LAR NRC Pre-submittal Meeting May 10, 2022 Proprietary (Redacted Version)

Supporting Framatome Analysis Summary

  • Framatome Topical Report ANP-3915P, Calvert Cliffs Misaligned CEA Evaluation

- Framatome performed calculations that validate extended operation at reduced power level with a single misaligned regulating rod.

  • [ The Framatome analysis considered the following conditions:

- Hot Full Power Initial-State (most limiting)

- Five (5) times in life (BOC, Early-MOC, MOC, Late-MOC and EOC)

- Location of the misaligned CEA

- Time spent at full power before power reduction (COLR Limit)

- Time at reduced power condition

- Analysis through duration of CEA recovery ]

1 CEA Recovery Time Improvement Privileged and Confidential FRAMATOME PROPRIETARY

Supporting Framatome Analysis Summary (cont.)

  • Analysis validated a reduction to 60% Reactor Thermal Power (RTP) provided adequate margin for safe operation

- [ FRT behavior for the analyzed conditions meet FRT LCO during operation at 60%

RTP

- Extended operation for up to 7 days

- 60% RTP must be maintained until the dropped CEA is fully recovered. ]

  • After the recovery of the misaligned CEA

- [ Reactor can return to full power using vendor supported ramp rate limits

- Evaluation of FRT until the return of steady state conditions ]

  • [ All LCOs must be met, including required actions, during the CEA misalignment and recovery ]

2 CEA Recovery Time Improvement Privileged and Confidential FRAMATOME PROPRIETARY

LAR Acceptance and Review

  • The Framatome ANP-3915P Licensing Report summarizes the methodology and approach and will be submitted by Constellation with the LAR
  • We intend to provide the detailed Framatome ANP-3915P Analysis Report to the NRC for review via a secure website 3 CEA Recovery Time Improvement Privileged and Confidential FRAMATOME PROPRIETARY